RFI-720656-2024-ENTOLOCAL: REQUEST FOR INFORMATION (RFI) USAID EntoLocal
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Mozambique USAID-Maputo notices from 2024.
Mozambique USAID-Maputo offered grants to any type of organization. Applications closed on August 28, 2024.
From the official notice on Grants.gov, last changed August 6, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeOther
Key dates
| Posted | July 17, 2024 |
|---|---|
| Deadline | August 28, 2024 |
| Archived by Grants.gov | September 13, 2024 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
USAID/Mozambique intends to design a new Activity - USAID EntoLocal - that will contribute to support the National Malaria Control Program and the National Institute of Health in planning and implementing entomological monitoring, and the provision of technical assistance for proven life-saving malaria vector control. This is anticipated to be a five (5) year award 2024 - 2029, with a total estimated value of approximately $15 million. The purpose of this communication is to obtain industry comment and input on the above-mentioned activity. More specifically, the RFI intends to: ○ Assess the interest of potential organizations in submitting applications/proposals for the new USAID EntoLocal Activity ○ Gain technical and organizational insights in the capacity of potential organizations. ○ Explore innovative approaches to partnering with organizations working in the same area; and ○ Collect inputs to contribute to the improvement of the proposed Program Description (PD)/Scope of Work (SOW).
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFI-720656-2024-ENTOLOCAL still open?
No. It closed on August 28, 2024.
Who can apply for REQUEST FOR INFORMATION (RFI) USAID EntoLocal?
Mozambique USAID-Maputo accepted applications from any type of organization.
What is the deadline for REQUEST FOR INFORMATION (RFI) USAID EntoLocal?
Closed August 28, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)